Cimzia® (certolizumab pegol)
for Arthritis Psoriatic

Cimzia (certolizumab pegol) is a TNF-alpha inhibitor used to treat various inflammatory conditions, including Crohn's disease, rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, polyarticular juvenile idiopathic arthritis, and non-radiographic axial spondyloarthritis in certain patients. It works by blocking TNFα, a protein that causes inflammation, thereby reducing symptoms and improving the patient's condition.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Arthritis Psoriatic